Go to deals
Private Equity | Healthcare | Industrial Machinery & Components

KKR to invest in Precipart Group Ltd.

Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.

Precipart, founded in 1950 by the Laubscher family with roots in Swiss engineering and manufacturing, is a leading contract development and manufacturing organization of highly engineered precision components and assemblies, primarily for the medical device industry as well as the aerospace and industrial markets. Precipart, through its mission to Engineer Possible, is a comprehensive solution provider supporting its customers from the concept phase to serial production and in managing their growing supply chain complexity. Major product offerings include precision machining, micro mechanical components, assemblies, gear systems, motion solutions, technical ceramics and advanced 3D printing.

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people and supporting growth in its portfolio companies and communities. KKR is investing in Precipart through its Health Care Strategic Growth Fund, a fund dedicated to investing in high-growth healthcare-related companies to which KKR can be a unique strategic partner in helping reach scale.

The Laubscher family remains highly committed to Precipart and is retaining a significant minority ownership stake in the company.

Oaklins’ team in Switzerland acted as the exclusive sell-side advisor to the shareholders of Precipart in the transaction. Oaklins TM Capital approached potential investors in the US market and supported the transaction at its early stages.

Parties
“My team, my family and I are thrilled to form this strategic partnership with KKR, who are the right partners to help take Precipart to the next level. The Oaklins team has been instrumental in concluding the transaction with our partner of choice. We have appreciated their high level of commitment, professionalism and guidance through the whole process.”

Oliver Laubscher

Member of the Board and CEO, Precipart Group Ltd.

Talk to the deal team

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland

Jens Rutten

Partner
Zurich, Switzerland
Oaklins Switzerland

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

John Dean

Associate Director
Atlanta, United States
Oaklins TM Capital

Christoph Walker

Associate Director
Zurich, Switzerland
Oaklins Switzerland

Related deals

Bolster Investment Partners has acquired a majority stake in Eternal Sun
Private Equity | Energy

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Learn more
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
Private Equity | Construction & Engineering Services | Energy | TMT

iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets

iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.

Learn more